SPINK1 protein expression and prostate cancer progression. - Wikidata - awgldk - TriplyDB

SPINK1 protein expression and prostate cancer progression.

SPINK1 protein expression and prostate cancer progression.

http://www.wikidata.org/entity/Q34203149

about

Prognostic outlier genes for enhanced prostate cancer treatment.Molecular pathways and targets in prostate cancer Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.Prostate cancer SubtyPINg biomarKers and outcome: is clarity emERGing?Ductal adenocarcinoma of the prostate: Clinical and biological profiles.Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis.Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance.RET Signaling in Prostate Cancer.Transcriptomic features of primary prostate cancer and their prognostic relevance to castration-resistant prostate cancer.SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion.

P2860

Q30244674-FF25E162-DA75-4EE2-86D4-41C15C8226EA Q34365632-A5348549-9B21-4DCF-A936-06FC852C33E8 Q35690915-B602F322-C3B9-48B4-89B9-28556A19F60E Q35983468-BBDC8401-3551-494E-8CC2-1A3EBFF8E245 Q36035812-33D79C00-C7CF-425B-B444-0439433BA5BF Q36471474-DE28A0F3-8A0B-4A5F-A462-2A46D1811F9E Q36546449-03F293AC-CEEC-4AA9-82C0-C726C6B29C0A Q36965321-7C1F23E4-9089-41F9-A157-33CD279E9C16 Q38221484-BB6E0317-276B-431E-9980-EED73435DD08 Q38683009-BEE7E388-6CA2-468E-8234-2D206D328BB5 Q38794223-EA8B467D-129B-4908-AC77-4566C23313DF Q40763465-1E3E1303-E886-4C0D-B981-EB7E694EF628 Q41016093-3C414BD3-D017-4D6F-AD0F-9E4CF8ADD1CD Q42120206-2BF8F036-28FA-405B-BFBE-677AB34DA0F7 Q42173139-E293FBBB-29E2-4692-A4F9-29214C4E59E0 Q47387082-70ADCA60-3207-4B4D-BB72-1876ADF63F29 Q47890656-46A19DC3-25B5-421F-8F64-6B4B7ED658E6 Q49231491-6111CB65-37D6-4FCD-81DE-8B6BC510344D Q51395627-F6DD1EB3-540C-46F3-AECA-B8FFEA1428C8

P2860

SPINK1 protein expression and prostate cancer progression.

http://www.wikidata.org/entity/Q34203149

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

SPINK1 protein expression and prostate cancer progression.

@ast

SPINK1 protein expression and prostate cancer progression.

@en

SPINK1 protein expression and prostate cancer progression.

@nl

type

label

SPINK1 protein expression and prostate cancer progression.

@ast

SPINK1 protein expression and prostate cancer progression.

@en

SPINK1 protein expression and prostate cancer progression.

@nl

prefLabel

SPINK1 protein expression and prostate cancer progression.

@ast

SPINK1 protein expression and prostate cancer progression.

@en

SPINK1 protein expression and prostate cancer progression.

@nl

P1433

Q34203149-E6A978FF-F46E-4AB3-BFEB-8E65762AF804

P1476

Q34203149-792BC7EE-D134-42E8-9FEC-0925E40EE8D2

P2093

Q34203149-02757970-94FF-4AFD-86A9-FED8A65E1027

Q34203149-11B420D8-A76C-4261-9905-8A51C5667C11

Q34203149-20217F21-89D4-4488-AF7F-A147D3D4E69F

Q34203149-2774E330-7631-4E3C-9B40-37747D1089CB

Q34203149-3479A2C5-1750-4ABF-9062-90FC88837876

Q34203149-494AD80D-0EC2-4945-B897-FE4F9045A2B1

Q34203149-51B3F759-4485-40FB-B0AD-DCEB21AC736A

Q34203149-5376CA4D-2337-4F6A-ABB1-6EB05EB9DCD4

Q34203149-77CC327D-A4A3-44C9-BD7F-65804B02BA6B

Q34203149-A65B1012-45BD-466F-84C4-E482571D9C05

P2860

Q34203149-04DA64B9-343D-477C-BCB6-41169CBB9018

Q34203149-05A72112-1D1B-4D82-83A0-9701949275A7

Q34203149-0B3F7D49-4040-4A16-A0B0-414920B9DAD9

Q34203149-124E1C38-80E9-4DBA-B1A6-3E2270FD6FED

Q34203149-202A6B6D-673C-450D-A618-4E142DC525B9

Q34203149-2267DFED-F60C-4074-B42C-7482BBAE3210

Q34203149-25F582F6-ECE1-4DA3-93C6-ED52FCC7FB29

Q34203149-2B508E9B-24B2-426D-BD66-DC7A23909D8F

Q34203149-2D5D9307-5CD8-447B-A586-C6CB22BE93A2

Q34203149-4A6BFF47-3DF0-43E1-A0CD-09A81378EC6A

P304

Q34203149-A3384AD2-065E-4BA6-9D2A-8EE0987AB9B3

P31

Q34203149-52920909-9482-47E0-B9A2-B2863753BD34

P356

Q34203149-29CF9969-CCEC-472D-8C90-AB99001DDB82

P407

Q34203149-32E4F6EF-02AB-4F57-A4A4-D8D6670CF71E

P433

Q34203149-DA30C3B2-48CD-4220-AAA7-35D360FBEBA4

P478

Q34203149-3F7213C1-B2D3-4FC6-9EDC-A9B2882B8BA3

P50

Q34203149-155B4BBC-3372-4A34-9DA3-F1D26FD5A88B

Q34203149-35BB92FC-7C20-4ACF-9562-0F9FB77C68A9

Q34203149-517678F5-67F9-45D6-BAE4-2DFF72D55840

Q34203149-6466FB3D-2BBD-4E38-860A-AF4842898788

Q34203149-689C652B-BBD8-4455-847C-AAEE72488A2B

Q34203149-8EA910B0-0C4A-44B5-9EB3-6D6849CA1DCC

Q34203149-9B05DE73-17EE-4248-8E02-5F2F171EC21F

Q34203149-9BE35120-7C43-48C9-8D9C-7D80E600C0B5

Q34203149-D8A87B38-2400-4811-A128-68712A0E0276

P577

Q34203149-B9F4CD30-FF77-4A5A-9DE6-148166711E54

P698

Q34203149-5E3F4015-8F22-4BDF-AFFE-C00D694ADA79

P932

Q34203149-C4EB29D9-BDD9-4026-BA36-DC7085A6DFE4

P356

1078-0432.CCR-13-1341

P1433

Clinical Cancer Research

P1476

SPINK1 protein expression and prostate cancer progression.

@en

P2093

Andreas Pettersson

http://www.w3.org/2001/XMLSchema#string

Christopher Fiore

http://www.w3.org/2001/XMLSchema#string

Christopher Sweeney

http://www.w3.org/2001/XMLSchema#string

Dyane Bailey

http://www.w3.org/2001/XMLSchema#string

Edward Stack

http://www.w3.org/2001/XMLSchema#string

Elizabeth Nuttall

http://www.w3.org/2001/XMLSchema#string

Gregory L Judson

http://www.w3.org/2001/XMLSchema#string

Howard D Sesso

http://www.w3.org/2001/XMLSchema#string

Jennifer Sinnott

http://www.w3.org/2001/XMLSchema#string

Kathryn L Penney

http://www.w3.org/2001/XMLSchema#string

P2860

The role of SPINK1 in ETS rearrangement-negative prostate cancers

Antibody-based detection of ERG rearrangement-positive prostate cancer

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

Therapeutic targeting of SPINK1-positive prostate cancer.

Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry.

The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis

Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.

Tenets of PTEN tumor suppression.

Aberrant cytoplasmic expression of p63 and prostate cancer mortality.

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression.

P304

4904-4911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-13-1341

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Edward Giovannucci

Stephen P. Finn

Jennifer R Stark

Philip W. Kantoff

Lorelei A Mucci

Meir J Stampfer

P577

2014-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24687926

http://www.w3.org/2001/XMLSchema#string

P932

4167171

http://www.w3.org/2001/XMLSchema#string